Press Release Bragar Eagel & Squire, P.C. Reminds Commvault Systems, Inc. (CVLT) Investors They Have Until July 17th to Contact the Firm Seeking Lead Plaintiff Role Bragar Eagel & Squire · Jul 3
Press Release CVLT Investors Have Opportunity to Lead Commvault Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm Schall Law · Jul 3
Press Release Kailas FUGA Team’s Ha Thi HAU Breaks Personal 100k Record at Western States Kailas FUGA · Jul 3
Press Release Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer Treos Bio Corp. · Jul 2
Press Release KTC Introduces H27E6, a 27-Inch WQHD 300Hz Monitor Built for Esports, Streaming, Creation, and Productivity KTC TECHNOLOGY (HONGKONG) CO., LIMITED · Jul 2
Press Release Bragar Eagel & Squire, P.C. Encourages BitGo Holdings, Inc. Investors with Large Losses to Contact the Firm Before August 7th Bragar Eagel & Squire · Jul 2
Press Release New Crypto: Ethereum Based Crypto Pepeto Nears Binance Debut While Cardano Price Target Turns Bullish Pepeto · Jul 2
Press Release Pep Club Launches Telehealth Platform Combining Prescription Therapy, Peptide Protocols, and At-Home Biomarker Testing Pep Club · Jul 2
Press Release Beisen Holdings Achieves Profitability in FY2026 Transitions to an Applied AI Company in Human Resources Beisen Holdings Limited · Jul 2
Press Release Edelson Lechtzin LLP Is Investigating The Swatch Group Over Tariff-Driven Price Increases That Were Not Refunded to Consumers After the Supreme Court Struck Down the Tariffs Edelson Lechtzin LLP · Jul 2
Press Release Momcozy Announces Multiple Amazon Best Seller Honors Across Maternity and Baby Care Categories During Prime Day 2026 Momcozy · Jul 2
Press Release Edelson Lechtzin LLP Is Investigating Hermès Over Tariff-Driven Price Increases That Were Not Refunded to Consumers After the Supreme Court Struck Down the Tariffs Edelson Lechtzin LLP · Jul 2
Press Release Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Milestone Pharmaceuticals Inc. · Jul 2